Skip to main content
. Author manuscript; available in PMC: 2020 Sep 2.
Published in final edited form as: Nat Med. 2020 Mar 2;26(3):387–397. doi: 10.1038/s41591-020-0762-2

Extended Data Fig. 2. Plasma Aβ 42/40 ratio per clinical diagnosis and Amyloid PET and FTP-PET status.

Extended Data Fig. 2

A. There was no difference in plasma Aβ 42/40 ratio between the different phenotypes(n=178). B. The Aβ 42/40 ratio was decreased in Amyloid PET positive cases (n=135). C. The Aβ 42/40 ratio was decreased in FTP-PET positive cases (n=76)